Cargando…

Pharmacokinetics of p-Aminohippuric Acid and Inulin in Rabbits with Aristolochic Acid Nephropathy

The characteristics of aristolochic acid nephropathy (AAN) are interstitial fibrosis and atrophy of the proximal tubules, but with no change in glomeruli. To investigate the effects of AA on renal functions and the pharmacokinetics (PKs) of p-aminohippuric acid (PAH) and inulin, New Zealand white ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tseng, Chiao-Shih, Chen, Shih-Ming, Chien, Shu-Chen, Hsu, Kuang-Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124128/ https://www.ncbi.nlm.nih.gov/pubmed/21738526 http://dx.doi.org/10.1155/2011/204501

Ejemplares similares

Update of aristolochic acid nephropathy in Korea
por: Ban, Tae Hyun, et al.
Publicado: (2018)

Overview of aristolochic acid nephropathy: an update
por: Zhou, Qingqing, et al.
Publicado: (2023)

Significant association between glycemic status and increased estimated postglomerular resistance in nondiabetic subjects – study of inulin and para-aminohippuric acid clearance in humans
por: Yasumoto, Mari, et al.
Publicado: (2015)

An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature
por: Jadot, Inès, et al.
Publicado: (2017)

Effects of aristolochic acid I and/or hypokalemia on tubular damage in C57BL/6 rat with aristolochic acid nephropathy
por: Yi, Joo-Hark, et al.
Publicado: (2018)

Spectrophotometric and colorimetric determination of gallium (III) with p-aminohippuric acid-functionalized citrate capped gold nanoparticles
por: AVAN, Asiye Aslıhan
Publicado: (2021)

Arterial Stiffness in Balkan Endemic Nephropathy, an Environmental Form of Aristolochic Acid Nephropathy
por: Premužić, Vedran, et al.
Publicado: (2018)

«Suspects» in Etiology of Endemic Nephropathy: Aristolochic Acid versus Mycotoxins
por: Pepeljnjak, Stjepan, et al.
Publicado: (2010)

The Ginsenoside Rg(1) Rescues Mitochondrial Disorders in Aristolochic Acid-Induced Nephropathic Mice
por: Chou, Chu-Kuang, et al.
Publicado: (2021)

Nephroprotective Role of Resveratrol and Ursolic Acid in Aristolochic Acid Intoxicated Zebrafish
por: Ding, Yu-Ju, et al.
Publicado: (2015)

Blockade of the mTOR signaling pathway with rapamycin ameliorates aristolochic acid nephropathy
por: Wu, Minmin, et al.
Publicado: (2020)

Smad7 protects against chronic aristolochic acid nephropathy in mice
por: Dai, Xiao-Yu, et al.
Publicado: (2015)

Protective Effects of Melatonin Against Aristolochic Acid-Induced Nephropathy in Mice
por: Kim, Jung-Yeon, et al.
Publicado: (2019)

Growing risk of aristolochic acid nephropathy in the era of COVID-19 – Correspondence
por: Das, Tuyelee, et al.
Publicado: (2022)

The Molecular Mechanism of Leptin Secretion and Expression Induced by Aristolochic Acid in Kidney Fibroblast
por: Lin, Tsung-Chieh, et al.
Publicado: (2011)

Targeting c-fms kinase attenuates chronic aristolochic acid nephropathy in mice
por: Dai, Xiao Y., et al.
Publicado: (2016)

Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy
por: Ishii, Takeo, et al.
Publicado: (2021)

Bioinformatics facilitating the use of microarrays to delineate potential miRNA biomarkers in aristolochic acid nephropathy
por: Lv, Yana, et al.
Publicado: (2016)

Effect of prednisolone on glyoxalase 1 in an inbred mouse model of aristolochic acid nephropathy using a proteomics method with fluorogenic derivatization-liquid chromatography-tandem mass spectrometry
por: Chen, Shih‐Ming, et al.
Publicado: (2020)

Prebiotics Inulin Metabolism by Lactic Acid Bacteria From Young Rabbits
por: Zhu, Yuan-ting, et al.
Publicado: (2021)

THE INTRARENAL DISTRIBUTION OF TRITIATED PARA-AMINOHIPPURIC ACID DETERMINED BY A MODIFIED TECHNIQUE OF SECTION FREEZE-DRY RADIOAUTOGRAPHY
por: Bordier, Betrand, et al.
Publicado: (1970)

Renal Protective Effects of 17β-Estradiol on Mice with Acute Aristolochic Acid Nephropathy
por: Shi, Min, et al.
Publicado: (2016)

Aristolochic acid nephropathy: A scientometric analysis of literature published from 1971 to 2019
por: Ji, Hongjian, et al.
Publicado: (2021)

Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition
por: Baudoux, Thomas, et al.
Publicado: (2022)

Ultrasound enhances the therapeutic potential of mesenchymal stem cells wrapped in greater omentum for aristolochic acid nephropathy
por: Yang, Yuanjun, et al.
Publicado: (2021)

Rapamycin protects against aristolochic acid nephropathy in mice by potentiating mammalian target of rapamycin-mediated autophagy
por: Lin, Fan, et al.
Publicado: (2021)

Integrative microRNA and mRNA expression profiling in acute aristolochic acid nephropathy in mice
por: Zhu, Ziqiang, et al.
Publicado: (2020)

Mesenchymal Stem Cell Derived Extracellular Vesicles Ameliorate Kidney Injury in Aristolochic Acid Nephropathy
por: Kholia, Sharad, et al.
Publicado: (2020)

Lycopene attenuates the inflammation and apoptosis in aristolochic acid nephropathy by targeting the Nrf2 antioxidant system
por: Wang, Yu, et al.
Publicado: (2022)

Renal angiotensin I-converting enzyme-deficient mice are protected against aristolochic acid nephropathy
por: Juretzko, Annett, et al.
Publicado: (2022)

Integrated single-cell transcriptomics and proteomics reveal cellular-specific responses and microenvironment remodeling in aristolochic acid nephropathy
por: Chen, Jiayun, et al.
Publicado: (2022)

Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using para-Aminohippuric Acid, With a Focus on SGLT2 Inhibitors
por: Scholtes, Rosalie A., et al.
Publicado: (2020)

Aristolochic Acid-Induced Genotoxicity and Toxicogenomic Changes in Rodents
por: Li, Xi-Lin, et al.
Publicado: (2020)

Dahuang Fuzi Decoction Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in Chronic Aristolochic Acid Nephropathy
por: Shui, Guang-xing, et al.
Publicado: (2017)

Interleukin-22 Attenuated Renal Tubular Injury in Aristolochic Acid Nephropathy via Suppressing Activation of NLRP3 Inflammasome
por: Wang, Shaofei, et al.
Publicado: (2019)

Macrophage interferon regulatory factor 4 deletion ameliorates aristolochic acid nephropathy via reduced migration and increased apoptosis
por: Sasaki, Kensuke, et al.
Publicado: (2022)

Preparation of Anti-Aristolochic Acid I Monoclonal Antibody and Development of Chemiluminescent Immunoassay and Carbon Dot-Based Fluoroimmunoassay for Sensitive Detection of Aristolochic Acid I
por: Ou, Ai-Fen, et al.
Publicado: (2021)

CD4(+) and CD8(+) T Cells Exert Regulatory Properties During Experimental Acute Aristolochic Acid Nephropathy
por: Baudoux, Thomas, et al.
Publicado: (2018)

Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy
por: Shan, Hongli, et al.
Publicado: (2020)

Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats
por: Bárta, František, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j28rqcnt1ub7lu7ea1b9o19bcs